Staphylococcus aureus infections

Epidemiology, pathophysiology, clinical manifestations, and management

Steven Y C Tong, Joshua S. Davis, Emily Eichenberger, Thomas L. Holland, Vance G. Fowler

    Research output: Contribution to journalArticleResearchpeer-review

    59 Downloads (Pure)

    Abstract

    Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.

    Original languageEnglish
    Pages (from-to)603-661
    Number of pages59
    JournalClinical Microbiology Reviews
    Volume28
    Issue number3
    DOIs
    Publication statusPublished - Jul 2015

    Fingerprint

    Staphylococcus aureus
    Epidemiology
    Endocarditis
    Infection
    Lactams
    Equipment and Supplies
    Skin
    Soft Tissue Infections
    Virulence Factors
    Cross Infection
    Bacteremia
    Anti-Bacterial Agents

    Cite this

    @article{66eaae619cb44d9a90abaaf96016baee,
    title = "Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management",
    abstract = "Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.",
    keywords = "antiinfective agent, antimicrobial therapy, Article, bacterial arthritis, bacterial endocarditis, catheter infection, clinical feature, device infection, disease course, epidural abscess, human, lung disease, meningitis, meta analysis (topic), nonhuman, osteoarthropathy, osteomyelitis, outcome assessment, pathophysiology, prosthesis infection, randomized controlled trial (topic), risk factor, skin infection, soft tissue infection, staphylococcal bacteremia, Staphylococcus infection, toxic shock syndrome, urinary tract infection, Staphylococcus aureus",
    author = "Tong, {Steven Y C} and Davis, {Joshua S.} and Emily Eichenberger and Holland, {Thomas L.} and Fowler, {Vance G.}",
    year = "2015",
    month = "7",
    doi = "10.1128/CMR.00134-14",
    language = "English",
    volume = "28",
    pages = "603--661",
    journal = "Clinical Microbiology Reviews",
    issn = "0893-8512",
    publisher = "American Society for Microbiology",
    number = "3",

    }

    Staphylococcus aureus infections : Epidemiology, pathophysiology, clinical manifestations, and management. / Tong, Steven Y C; Davis, Joshua S.; Eichenberger, Emily; Holland, Thomas L.; Fowler, Vance G.

    In: Clinical Microbiology Reviews, Vol. 28, No. 3, 07.2015, p. 603-661.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Staphylococcus aureus infections

    T2 - Epidemiology, pathophysiology, clinical manifestations, and management

    AU - Tong, Steven Y C

    AU - Davis, Joshua S.

    AU - Eichenberger, Emily

    AU - Holland, Thomas L.

    AU - Fowler, Vance G.

    PY - 2015/7

    Y1 - 2015/7

    N2 - Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.

    AB - Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to β-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.

    KW - antiinfective agent

    KW - antimicrobial therapy

    KW - Article

    KW - bacterial arthritis

    KW - bacterial endocarditis

    KW - catheter infection

    KW - clinical feature

    KW - device infection

    KW - disease course

    KW - epidural abscess

    KW - human

    KW - lung disease

    KW - meningitis

    KW - meta analysis (topic)

    KW - nonhuman

    KW - osteoarthropathy

    KW - osteomyelitis

    KW - outcome assessment

    KW - pathophysiology

    KW - prosthesis infection

    KW - randomized controlled trial (topic)

    KW - risk factor

    KW - skin infection

    KW - soft tissue infection

    KW - staphylococcal bacteremia

    KW - Staphylococcus infection

    KW - toxic shock syndrome

    KW - urinary tract infection

    KW - Staphylococcus aureus

    UR - http://www.scopus.com/inward/record.url?scp=84930239306&partnerID=8YFLogxK

    U2 - 10.1128/CMR.00134-14

    DO - 10.1128/CMR.00134-14

    M3 - Article

    VL - 28

    SP - 603

    EP - 661

    JO - Clinical Microbiology Reviews

    JF - Clinical Microbiology Reviews

    SN - 0893-8512

    IS - 3

    ER -